The San Diego-based biotech announced the closing of its $95 million ... unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.
News
- Novo and Abingworth back a $95M Series B for Reneo Pharmaceuticals, which aims to treat ...
- Pascal Biosciences and SōRSE Technology Optimize Cannabinoid Formulation for Clinical ...
Pascal is a biotechnology company targeting innovative therapies for ... for the Treatment of Breast Cancer at the 2020 San Antonio Breast Cancer ...
- Seagen Highlights TUKYSA® (tucatinib) Data in Breast Cancer at Virtual 2020 San Antonio Breast ...
Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful ...
- India says it may approve vaccine in weeks, outlines plan
Bharat Biotech applied for a license for its experimental inactivated virus vaccine without completing phase-three trials, they said. According to Indian ...
- The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On ...
Evelo Biosciences Inc (NASDAQ: EVLO) will present at the San Antonio Breast Cancer Symposium with a poster of additional data from a Phase 1/2 ...